L
Laureline Berteloot
Researcher at Necker-Enfants Malades Hospital
Publications - 69
Citations - 1497
Laureline Berteloot is an academic researcher from Necker-Enfants Malades Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 61 publications receiving 871 citations. Previous affiliations of Laureline Berteloot include University of Paris & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot,Thomas Blanc,Thomas Blanc,Thomas Blanc,Smail Hadj Rabia,Smail Hadj Rabia,Laureline Berteloot,Sophia Ladraa,J P Duong,J P Duong,Estelle Blanc,Simon C. Johnson,Clément Hoguin,Olivia Boccara,Sabine Sarnacki,Sabine Sarnacki,Nathalie Boddaert,Nathalie Boddaert,Stéphanie Pannier,Stéphanie Pannier,Frank Martinez,Sato Magassa,Junna Yamaguchi,Bertrand Knebelmann,Bertrand Knebelmann,Bertrand Knebelmann,Pierre Merville,Nicolas Grenier,Dominique Joly,Dominique Joly,Dominique Joly,Valérie Cormier-Daire,Valérie Cormier-Daire,Caroline Michot,Caroline Michot,Christine Bole-Feysot,Arnaud Picard,Arnaud Picard,Véronique Soupre,Stanislas Lyonnet,Stanislas Lyonnet,Jérémy Sadoine,Lotfi Slimani,Catherine Chaussain,Cécile Laroche-Raynaud,Laurent Guibaud,Christine Broissand,Jeanne Amiel,Jeanne Amiel,Christophe Legendre,Christophe Legendre,Christophe Legendre,Fabiola Terzi,Fabiola Terzi,Guillaume Canaud,Guillaume Canaud,Guillaume Canaud +56 more
TL;DR: This study provides the first direct evidence supporting PIK3CA inhibition as a promising therapeutic strategy in patients with PROS, by reversing symptoms in a mouse model of PROS/CLOVES syndrome, which results from gain-of-function mutations in PI3KCA.
Journal ArticleDOI
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children
Marie-Louise Frémond,Marie-Louise Frémond,Marie-Louise Frémond,Mathieu P Rodero,Mathieu P Rodero,Nadia Jeremiah,Alexandre Belot,Eric Jeziorski,Darragh Duffy,Didier Bessis,Guilhem Cros,Gillian I. Rice,Bruno Charbit,Anne Hulin,Nihel Khoudour,Consuelo Modesto Caballero,Christine Bodemer,Monique Fabre,Laureline Berteloot,Muriel Le Bourgeois,Philippe Reix,Thierry Walzer,Despina Moshous,Stéphane Blanche,Stéphane Blanche,Alain Fischer,Brigitte Bader-Meunier,Frédéric Rieux-Laucat,Yanick J. Crow,Yanick J. Crow,Yanick J. Crow,Bénédicte Neven,Bénédicte Neven,Bénédicte Neven +33 more
TL;DR: This book aims to provide a history of Quebec and its people from 1989 to 2002, a period chosen in order to explore its roots as well as specific cases up to and including the year in whichMarie-Louise Frémond died.
Journal ArticleDOI
Severe and fatal forms of COVID-19 in children.
Mehdi Oualha,M. Bendavid,Laureline Berteloot,Alice Corsia,F. Lesage,M. Vedrenne,Elodie Salvador,Marion Grimaud,Judith Chareyre,C. de Marcellus,L. Dupic,L. de Saint Blanquat,C. Heilbronner,David Drummond,M. Castelle,Romain Berthaud,François Angoulvant,Julie Toubiana,Y. Pinhas,Pierre Frange,G. Chéron,Jacques Fourgeaud,Florence Moulin,Sylvain Renolleau +23 more
TL;DR: This study highlighted the large spectrum of clinical presentation and time course of disease progression as well as the non-negligible occurrence of pediatric life-threatening and fatal cases of COVID-19 mostly in patients with comorbidities.
Journal ArticleDOI
Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn’s Disease
Inbar Weinstein-Nakar,Gili Focht,Peter C Church,Thomas D. Walters,Guila Abitbol,Sudha A. Anupindi,Laureline Berteloot,Jessie M. Hulst,Frank M. Ruemmele,Daniel A. Lemberg,Steven T. Leach,Ruth Cytter,Mary-Louise C. Greer,Anne M. Griffiths,Dan Turner +14 more
TL;DR: In a prospective study of children with CD, one‐third have healing in only the mucosa or the bowel wall (not both); levels of fecal calprotectin below 300 &mgr;g/identify children with mucosal healing, but a lower cutoff value is needed to identify children with deep healing.
Journal ArticleDOI
Model-based iterative reconstruction in pediatric chest CT: assessment of image quality in a prospective study of children with cystic fibrosis.
F. Miéville,Laureline Berteloot,Albane Grandjean,Paul Ayestaran,François Gudinchet,Sabine Schmidt,Francis Brunelle,François Bochud,Francis R. Verdun +8 more
TL;DR: At minimum-dose CT, VEO enables important dose reduction depending on the clinical indication and makes visible certain small structures that were not perceptible with filtered back-projection.